Next Article in Journal
Features of Occupational Health Risks in the Russian Arctic (on the Example of Nenets Autonomous Okrug and Chukotka Autonomous Okrug)
Next Article in Special Issue
Influenza Vaccine Effectiveness and Waning Effect in Hospitalized Older Adults. Valencia Region, Spain, 2018/2019 Season
Previous Article in Journal
Family Orchards and Health-Related Quality of Life in the Elderly. A Protocol for a Study in Las Hurdes (Spain) Based on an Ethnographic Approach
Previous Article in Special Issue
No Evidence of SARS-CoV-2 Circulation in Rome (Italy) during the Pre-Pandemic Period: Results of a Retrospective Surveillance
 
 
Article

Challenges and Adaptation of a European Influenza Vaccine Effectiveness Study Platform in Response to the COVID-19 Emergence: Experience from the DRIVE Project

1
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunidad Valenciana (Fisabio), Avenida Cataluña 21, 46020 Valencia, Spain
2
P-95 CVBA, Koning Leopold III laan 1, 3001 Heverlee, Belgium
3
INSERM CIC 1417, Assistance Publique-Hôpitaux de Paris, Université de Paris, Hôpital Cochin, 75005 Paris, France
4
Sanofi-Pasteur SA (SP), 14 Espace Henry Vallée, 69007 Lyon, France
*
Author to whom correspondence should be addressed.
Academic Editor: Paul B. Tchounwou
Int. J. Environ. Res. Public Health 2021, 18(3), 1058; https://doi.org/10.3390/ijerph18031058
Received: 29 December 2020 / Revised: 19 January 2021 / Accepted: 20 January 2021 / Published: 25 January 2021
The Development of Robust and Innovative Vaccine Effectiveness (DRIVE) project is a public–private partnership aiming to build capacity in Europe for yearly estimation of brand-specific influenza vaccine effectiveness (IVE). DRIVE is a five-year project funded by IMI (Innovative Medicines Initiative). It was initiated as a response to the guidance on influenza vaccines by EMA (European Medicines Agency), which advised vaccine manufacturers to work with public health institutes to set up a joint IVE study platform. The COVID-19 pandemic reached Europe in February 2020 and overlapped with the 2019/2020 influenza season only in the last weeks. However, several elements of the DRIVE study network were impacted. The pandemic specifically affected the study sites’ routines and the subsequent assessment of the 2019/20 influenza season. Moreover, the current social distancing measures and lockdown policies across Europe are expected to also limit the circulation of influenza for the 2020/21 season, and therefore the impact of COVID-19 will be higher than in the season 2019/20. Consequently, DRIVE has planned to adapt its study platform to the COVID-19 challenge, encompassing several COVID-19 particularities in the study procedures, data collection and IVE analysis for the 2020/21 season. DRIVE will study the feasibility of implementing these COVID-19 components and establish the foundations of future COVID-19 vaccine effectiveness studies. View Full-Text
Keywords: COVID-19; influenza; vaccination; vaccine effectiveness; test-negative design COVID-19; influenza; vaccination; vaccine effectiveness; test-negative design
Show Figures

Figure 1

MDPI and ACS Style

Carmona, A.; Muñoz-Quiles, C.; Stuurman, A.; Descamps, A.; Mira-Iglesias, A.; Torcel-Pagnon, L.; Díez-Domingo, J. Challenges and Adaptation of a European Influenza Vaccine Effectiveness Study Platform in Response to the COVID-19 Emergence: Experience from the DRIVE Project. Int. J. Environ. Res. Public Health 2021, 18, 1058. https://doi.org/10.3390/ijerph18031058

AMA Style

Carmona A, Muñoz-Quiles C, Stuurman A, Descamps A, Mira-Iglesias A, Torcel-Pagnon L, Díez-Domingo J. Challenges and Adaptation of a European Influenza Vaccine Effectiveness Study Platform in Response to the COVID-19 Emergence: Experience from the DRIVE Project. International Journal of Environmental Research and Public Health. 2021; 18(3):1058. https://doi.org/10.3390/ijerph18031058

Chicago/Turabian Style

Carmona, Antonio, Cintia Muñoz-Quiles, Anke Stuurman, Alexandre Descamps, Ainara Mira-Iglesias, Laurence Torcel-Pagnon, and Javier Díez-Domingo. 2021. "Challenges and Adaptation of a European Influenza Vaccine Effectiveness Study Platform in Response to the COVID-19 Emergence: Experience from the DRIVE Project" International Journal of Environmental Research and Public Health 18, no. 3: 1058. https://doi.org/10.3390/ijerph18031058

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop